Ira Dunkel, MD [clinicaltrials_resource:e5e5cee103cb4ca9a03d7b82f821bec0]
Chemotherapy in Treating Patients With Retinoblastoma [clinicaltrials:NCT00002675]High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003173]Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers [clinicaltrials:NCT00003754]clinicaltrials:NCT00058370
overall official [clinicaltrials_vocabulary:overall-official]
Ira Dunkel, MD [clinicaltrials_resource:e5e5cee103cb4ca9a03d7b82f821bec0]
Bio2RDF identifier
e5e5cee103cb4ca9a03d7b82f821bec0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e5e5cee103cb4ca9a03d7b82f821bec0
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Ira Dunkel, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:e5e5cee103cb4ca9a03d7b82f821bec0
title
Ira Dunkel, MD
@en
type
label
Ira Dunkel, MD [clinicaltrials_resource:e5e5cee103cb4ca9a03d7b82f821bec0]
@en